Kopran Limited (BOM:524280)
India flag India · Delayed Price · Currency is INR
120.40
-2.55 (-2.07%)
At close: Mar 9, 2026

Kopran Company Description

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally.

The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations.

It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, sterile carbapenem, urological, neuromodulator, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular.

In addition, the company offers drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others.

Kopran Limited was incorporated in 1958 and is based in Mumbai, India.

Kopran Limited
Country India
Founded 1958
Industry Pharmaceutical Preparations
Employees 1,024
CEO Surendra Somani

Contact Details

Address:
Parijat House
Mumbai, 400018
India
Phone 91 22 4366 1111
Website kopran.com

Stock Details

Ticker Symbol 524280
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Surendra Somani Chief Executive Officer
Basant Soni Chief Financial Officer
Ajit Jain Chief Operating Officer